Legal & General Group’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $353K | Sell |
31,077
-4,270
| -12% | -$48.5K | ﹤0.01% | 2532 |
|
|
2025
Q1 | $235K | Hold |
35,347
| – | – | ﹤0.01% | 2584 |
|
|
2024
Q4 | $390K | Buy |
35,347
+1,540
| +5% | +$17K | ﹤0.01% | 2546 |
|
|
2024
Q3 | $415K | Buy |
33,807
+1,017
| +3% | +$12.5K | ﹤0.01% | 2523 |
|
|
2024
Q2 | $443K | Buy |
32,790
+30,512
| +1,339% | +$412K | ﹤0.01% | 2457 |
|
|
2024
Q1 | $30.8K | Sell |
2,278
-851
| -27% | -$11.5K | ﹤0.01% | 2849 |
|
|
2023
Q4 | $16.5K | Sell |
3,129
-7,805
| -71% | -$41.1K | ﹤0.01% | 3108 |
|
|
2023
Q3 | $43.1K | Sell |
10,934
-4,258
| -28% | -$16.8K | ﹤0.01% | 2885 |
|
|
2023
Q2 | $161K | Buy |
15,192
+11,971
| +372% | +$127K | ﹤0.01% | 2783 |
|
|
2023
Q1 | $26.8K | Sell |
3,221
-3,077
| -49% | -$25.6K | ﹤0.01% | 2989 |
|
|
2022
Q4 | $58.1K | Hold |
6,298
| – | – | ﹤0.01% | 2925 |
|
|
2022
Q3 | $81K | Buy |
6,298
+1,056
| +20% | +$13.6K | ﹤0.01% | 2877 |
|
|
2022
Q2 | $69K | Sell |
5,242
-39
| -0.7% | -$513 | ﹤0.01% | 2941 |
|
|
2022
Q1 | $111K | Hold |
5,281
| – | – | ﹤0.01% | 2840 |
|
|
2021
Q4 | $127K | Buy |
5,281
+29
| +0.6% | +$697 | ﹤0.01% | 2857 |
|
|
2021
Q3 | $134K | Buy |
5,252
+2,532
| +93% | +$64.6K | ﹤0.01% | 2789 |
|
|
2021
Q2 | $92K | Buy |
2,720
+715
| +36% | +$24.2K | ﹤0.01% | 2770 |
|
|
2021
Q1 | $78K | Buy |
2,005
+220
| +12% | +$8.56K | ﹤0.01% | 2687 |
|
|
2020
Q4 | $110K | Sell |
1,785
-555
| -24% | -$34.2K | ﹤0.01% | 2563 |
|
|
2020
Q3 | $79K | Buy |
2,340
+281
| +14% | +$9.49K | ﹤0.01% | 2552 |
|
|
2020
Q2 | $49K | Sell |
2,059
-559
| -21% | -$13.3K | ﹤0.01% | 2735 |
|
|
2020
Q1 | $60K | Buy |
2,618
+816
| +45% | +$18.7K | ﹤0.01% | 2547 |
|
|
2019
Q4 | $51K | Buy |
1,802
+312
| +21% | +$8.83K | ﹤0.01% | 2805 |
|
|
2019
Q3 | $32K | Buy |
+1,490
| New | +$32K | ﹤0.01% | 2940 |
|